Jade Biosciences (JBIO) Tax Provisions (2024 - 2026)

Jade Biosciences' (JBIO) quarterly Tax Provisions came in at $100000.0 in Q1 2026.

Analysis

Jade Biosciences (JBIO) Tax Provisions (2024 - 2026) Analysis & Trends

Jade Biosciences (JBIO) has 1 years of Tax Provisions data on file, last reported at $100000.0 in Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	138.78 Bn	130.92 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.50 Bn	77.51 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	63.51 Bn	58.32 Bn	1.37 Bn	-59.00 Mn
4	Moderna	58.06 Bn	52.92 Bn	52.00 Mn	15.00 Mn
5	Revolution Medicines	44.04 Bn	44.04 Bn	-	-
6	BeOne Medicines	40.04 Bn	34.94 Bn	1.53 Bn	75.45 Mn
7	Alnylam Pharmaceuticals	35.45 Bn	32.14 Bn	992.69 Mn	13.31 Mn
8	Royalty Pharma	28.41 Bn	27.57 Bn	-	-
9	Insmed	27.42 Bn	26.26 Bn	358.27 Mn	1.90 Mn
10	Jade Biosciences	1.22 Bn	1.22 Bn	-	15,000.00

Historic Data

Download Data